| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Spandow Oliver J. | Director | C/O NEPHROS, INC., 380 LACKAWANNA PLACE, SOUTH ORANGE | /s/ Christopher Melsha as attorney-in-fact for Oliver Spandow pursuant to power of attorney previously filed. | 13 Nov 2025 | 0001749836 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEPH | Common Stock | Award | $0 | +8,036 | +7% | $0.000000 | 122,881 | 10 Nov 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NEPH | Stock Option (Right to Buy) | 9,466 | 10 Nov 2025 | Common Stock | 9,466 | $5.58 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 5,161 | 10 Nov 2025 | Common Stock | 5,161 | $5.85 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 5,568 | 10 Nov 2025 | Common Stock | 5,568 | $8.57 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 6,850 | 10 Nov 2025 | Common Stock | 6,850 | $8.06 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 7,062 | 10 Nov 2025 | Common Stock | 7,062 | $6.82 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 7,080 | 10 Nov 2025 | Common Stock | 7,080 | $1.07 | Direct | F1 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 7,323 | 10 Nov 2025 | Common Stock | 7,323 | $2.14 | Direct | F2 | |||||
| holding | NEPH | Stock Option (Right to Buy) | 7,050 | 10 Nov 2025 | Common Stock | 7,050 | $1.47 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Fully exercisable. |
| F2 | This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26. |
| F3 | This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27. |